HOME >> BIOLOGY >> NEWS
Scientists report on promising new approaches to induce cancer cell suicide

In cancer, the normal process by which cells die is defective. Researchers are reporting today on three new approaches to activate cancer cells' ability to commit suicide. In one set of studies, scientists employed a series of molecular and gene therapy tricks to convert an angiogenic protein used by tumors to promote their growth into a cancer cell killer. In separate study, scientists used a fragment of genetic material to disable a protein used by many tumor types as an "off switch" to prevent cell death, triggering cancer cell suicide. A third study focused on a novel inhibitor to improve responses to central nervous system tumor therapy. The findings were presented today at the International Conference on Molecular Targets and Cancer Therapeutics organized by the American Association of Cancer Research (AACR), National Cancer Institute (NCI) and European Organisation for Research and Treatment of Cancer (EORTC) in Boston.

Antisense inhibition of survivin expression as a cancer therapeutic: Abstract 324

Scientists have inhibited cancer in mice using a synthetic fragment of genetic material to block production of a protein that many tumor types use to survive. Researchers at Eli Lilly and Company reported the studies of the compound, LY2181308, which is directed against a molecular target called survivin.

Survivin belongs to a family of proteins, called Inhibitor of Apoptosis Proteins, which play a key role in the regulation of apoptosis and cell division. The protein is expressed in a majority of human cancers but not in normal adult tissues, making it a potential target for cancer therapies. LY2181308 is an anti-sense oligonucleotide that potently downregulated survivin expression in human cancer cells derived from lung, colon, breast, prostate, ovary, cervix, skin and brain.

"We believe that the use of antisense molecules against targets such as survivin are a viable option for the treatment and management of cancer patients, ei
'"/>

Contact: Warren Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
20-Nov-2003


Page: 1 2 3 4

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2020)... ... February 06, 2020 , ... Kerafast Inc. , ... materials, today announced an agreement with The Good Food Institute , a ... Under the partnership, terrestrial meat and aquatic cell lines will be made available ...
(Date:1/30/2020)... (PRWEB) , ... January 30, 2020 , ... Accelera ... an eye on the Canadian market, is pleased to announce that the company has ... growth since the company launched in 2017. , “We are so thrilled to ...
(Date:1/28/2020)... PRUSSIA, Pa. and CAMBRIDGE, Mass. (PRWEB) , ... ... ... to solving complex problems for life sciences companies and government agencies, announced that ... life sciences hubs in the country. Tunnell’s Cambridge office will be in the ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... , ... February 19, 2020 , ... ... solutions for the life sciences industry, today announced the opening of a new ... Associate Partner, Red Nucleus R&D. , Red Nucleus announced the new office in ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... from a long-term follow-up clinical study of outpatient L4-L5 lumbar interspinous fixation ... Unlike extension block design, the Inspan device fixates the spine to allow ...
(Date:2/10/2020)... ... February 10, 2020 , ... R3 Medical Training announced it is now registering ... Las Vegas. The course is hands on involving real patients and stem cell biologics, ... the Comprehensive Stem Cell Training Course has received rave reviews from attendees, who love ...
(Date:2/5/2020)... ... February 05, 2020 , ... Rare Disease Day® , held the ... Organization for Rare Disorders (NORD), to raise awareness amongst the general public and decision-makers ... Balancing Act’s “Behind The Mystery” rare disease series will be shining the ...
Breaking Biology Technology:
Cached News: